ESC 2018: GLOBAL LEADERS TRIAL - Dr Patrick Serruys

 

Dr Patrick Serruys (Imperial College, London, UK) discusses GLOBAL LEADERS TRIAL - A randomized comparison of 24 month ticagrelor and 1 month aspirin versus 12 month dual antiplatelet therapy followed by aspirin monotherapy

Filmed on-site at ESC 2018